Kelly Londy CCO for Accuray
This article was originally published in Scrip
Executive Summary
Accuray, a radiation oncology company, has appointed Kelly Londy senior vice-president and chief commercial officer, effective 1 October 2011. Ms Londy previously served as vice-president and general manager of molecular imaging at GE Healthcare North America.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.